AG˹ٷ

STOCK TITAN

[Form 4] Amrize Ltd Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

James J. Gosa, who is identified as an officer (President, Building Envelope) and a director of Amrize Ltd (AMRZ), was awarded restricted stock units on 08/11/2025 under the Amrize Ltd 2025 Omnibus Incentive Plan. Two awards were reported: 36,952 RSUs that vest on March 21, 2026 and 18,687 RSUs that vest on March 21, 2027. Both grants are recorded with a price of $0.

Following these reported transactions the filing shows the reporting person beneficially owns 55,639 ordinary shares on a direct basis. The entries are presented as non-derivative security acquisitions (restricted stock unit awards) with the vesting schedule and award source explicitly stated in the explanations.

James J. Gosa, identificato come dirigente (President, Building Envelope) e membro del consiglio di Amrize Ltd (AMRZ), ha ricevuto unità azionarie vincolate il 08/11/2025 nell'ambito del Amrize Ltd 2025 Omnibus Incentive Plan. Sono stati segnalati due premi: 36,952 RSU che maturano il 21 marzo 2026 e 18,687 RSU che maturano il 21 marzo 2027. Entrambe le assegnazioni sono registrate con un prezzo di $0.

A seguito di queste operazioni, la dichiarazione indica che la persona segnalante detiene beneficiariamente 55,639 azioni ordinarie su base diretta. Le voci sono presentate come acquisizioni di titoli non derivati (assegnazioni di unità azionarie vincolate) con il calendario di maturazione e la fonte dell'assegnazione esplicitati nelle spiegazioni.

James J. Gosa, identificado como funcionario (President, Building Envelope) y miembro del consejo de Amrize Ltd (AMRZ), recibió unidades restringidas de acciones el 08/11/2025 en virtud del Amrize Ltd 2025 Omnibus Incentive Plan. Se informaron dos adjudicaciones: 36,952 RSU que vencen el 21 de marzo de 2026 y 18,687 RSU que vencen el 21 de marzo de 2027. Ambas asignaciones constan con un precio de $0.

Tras estas transacciones notificadas, la presentación muestra que la persona informante posee beneficiariamente 55,639 acciones ordinarias de forma directa. Las partidas se presentan como adquisiciones de valores no derivados (adjudicaciones de unidades restringidas) con el calendario de adquisición y la fuente de la adjudicación explícitos en las explicaciones.

James J. Gosa� 임원( President, Building Envelope )이자 Amrize Ltd(AMRZ)� 이사� 확인되며, Amrize Ltd 2025 Omnibus Incentive Plan� 따라 08/11/2025� 제한부 주식단위(RSU)� 부여받았습니다. 보고� 수여� � 건으�, 36,952 鳧� 2026� 3� 21�� 권리확정(베스�)되고 18,687 鳧� 2027� 3� 21�� 권리확정됩니�. � � 모두 $0� 가격으� 기록되어 있습니다.

이들 거래 보고 � 제출서류에는 보고인이 직접적으� 유익하게 보유� 보통� 55,639주가 기재되어 있습니다. 항목들은 권리확정 일정� 수여 출처가 설명� 명시� 비파� 증권 취득(제한부 주식단위 수여)으로 제시되어 있습니다.

James J. Gosa, identifié comme dirigeant (President, Building Envelope) et administrateur d'Amrize Ltd (AMRZ), s'est vu attribuer des unités d'actions restreintes le 08/11/2025 dans le cadre du Amrize Ltd 2025 Omnibus Incentive Plan. Deux attributions ont été signalées : 36,952 RSU qui acquièrent leurs droits le 21 mars 2026 et 18,687 RSU qui acquièrent leurs droits le 21 mars 2027. Les deux attributions sont enregistrées avec un prix de $0.

Suite à ces opérations déclarées, le dépôt indique que la personne déclarante détient à titre bénéficiaire 55,639 actions ordinaires en propriété directe. Les éléments sont présentés comme des acquisitions de titres non dérivés (attributions d'unités d'actions restreintes) avec le calendrier d'acquisition et la source de l'attribution explicitement indiqués dans les explications.

James J. Gosa, der als Officer (President, Building Envelope) und als Direktor von Amrize Ltd (AMRZ) ausgewiesen ist, erhielt am 08/11/2025 Restricted Stock Units im Rahmen des Amrize Ltd 2025 Omnibus Incentive Plan. Es wurden zwei Zuteilungen gemeldet: 36,952 RSUs, die am 21. März 2026 vesten, und 18,687 RSUs, die am 21. März 2027 vesten. Beide Zuteilungen sind mit einem Preis von $0 verbucht.

Nach diesen gemeldeten Transaktionen zeigt die Einreichung, dass die meldepflichtige Person unmittelbar beteiligungsberechtigt 55,639 Stammaktien besitzt. Die Einträge werden als Erwerb von nicht-derivativen Wertpapieren (Restricted Stock Unit-Zuteilungen) dargestellt, wobei der Vesting-Zeitplan und die Herkunft der Zuteilung in den Erläuterungen ausdrücklich angegeben sind.

Positive
  • Grant of 55,639 RSUs to the reporting person is explicitly documented (36,952 and 18,687 units).
  • Clear vesting schedule is provided: vesting on March 21, 2026 and March 21, 2027.
Negative
  • Grants recorded at $0, indicating no cash consideration in the transactions as reported.
  • Filing does not disclose outstanding share count or percentage dilution, so ownership impact relative to total shares is unspecified.

Insights

TL;DR: Officer-director received time‑based RSU awards totaling 55,639 shares with two distinct vesting dates, disclosed under the 2025 Omnibus Plan.

The Form 4 discloses typical equity-based compensation rather than a sale or transfer. The awards are structured as restricted stock units granted at $0 that vest in two installments on March 21, 2026 and March 21, 2027. As disclosed, these are direct beneficial holdings after the grants. This is a routine disclosure for insider compensation; the filing provides clear dates, amounts, and plan reference but no information on the aggregate dilution relative to outstanding shares or performance conditions beyond vesting dates.

TL;DR: Insider acquired 55,639 shares via RSUs on 08/11/2025; awards vest over two years and are recorded as non‑derivative acquisitions.

The transaction entries report two restricted stock unit awards totaling 55,639 ordinary shares granted under the 2025 Omnibus Incentive Plan and recorded with a $0 price. The filing lists direct beneficial ownership following the transactions as 55,639 shares. There are no derivative instruments, no cash proceeds, and no exercises or sales reported. The disclosure is concise and focused on grant mechanics and vesting schedule; market impact cannot be assessed from the filing alone.

James J. Gosa, identificato come dirigente (President, Building Envelope) e membro del consiglio di Amrize Ltd (AMRZ), ha ricevuto unità azionarie vincolate il 08/11/2025 nell'ambito del Amrize Ltd 2025 Omnibus Incentive Plan. Sono stati segnalati due premi: 36,952 RSU che maturano il 21 marzo 2026 e 18,687 RSU che maturano il 21 marzo 2027. Entrambe le assegnazioni sono registrate con un prezzo di $0.

A seguito di queste operazioni, la dichiarazione indica che la persona segnalante detiene beneficiariamente 55,639 azioni ordinarie su base diretta. Le voci sono presentate come acquisizioni di titoli non derivati (assegnazioni di unità azionarie vincolate) con il calendario di maturazione e la fonte dell'assegnazione esplicitati nelle spiegazioni.

James J. Gosa, identificado como funcionario (President, Building Envelope) y miembro del consejo de Amrize Ltd (AMRZ), recibió unidades restringidas de acciones el 08/11/2025 en virtud del Amrize Ltd 2025 Omnibus Incentive Plan. Se informaron dos adjudicaciones: 36,952 RSU que vencen el 21 de marzo de 2026 y 18,687 RSU que vencen el 21 de marzo de 2027. Ambas asignaciones constan con un precio de $0.

Tras estas transacciones notificadas, la presentación muestra que la persona informante posee beneficiariamente 55,639 acciones ordinarias de forma directa. Las partidas se presentan como adquisiciones de valores no derivados (adjudicaciones de unidades restringidas) con el calendario de adquisición y la fuente de la adjudicación explícitos en las explicaciones.

James J. Gosa� 임원( President, Building Envelope )이자 Amrize Ltd(AMRZ)� 이사� 확인되며, Amrize Ltd 2025 Omnibus Incentive Plan� 따라 08/11/2025� 제한부 주식단위(RSU)� 부여받았습니다. 보고� 수여� � 건으�, 36,952 鳧� 2026� 3� 21�� 권리확정(베스�)되고 18,687 鳧� 2027� 3� 21�� 권리확정됩니�. � � 모두 $0� 가격으� 기록되어 있습니다.

이들 거래 보고 � 제출서류에는 보고인이 직접적으� 유익하게 보유� 보통� 55,639주가 기재되어 있습니다. 항목들은 권리확정 일정� 수여 출처가 설명� 명시� 비파� 증권 취득(제한부 주식단위 수여)으로 제시되어 있습니다.

James J. Gosa, identifié comme dirigeant (President, Building Envelope) et administrateur d'Amrize Ltd (AMRZ), s'est vu attribuer des unités d'actions restreintes le 08/11/2025 dans le cadre du Amrize Ltd 2025 Omnibus Incentive Plan. Deux attributions ont été signalées : 36,952 RSU qui acquièrent leurs droits le 21 mars 2026 et 18,687 RSU qui acquièrent leurs droits le 21 mars 2027. Les deux attributions sont enregistrées avec un prix de $0.

Suite à ces opérations déclarées, le dépôt indique que la personne déclarante détient à titre bénéficiaire 55,639 actions ordinaires en propriété directe. Les éléments sont présentés comme des acquisitions de titres non dérivés (attributions d'unités d'actions restreintes) avec le calendrier d'acquisition et la source de l'attribution explicitement indiqués dans les explications.

James J. Gosa, der als Officer (President, Building Envelope) und als Direktor von Amrize Ltd (AMRZ) ausgewiesen ist, erhielt am 08/11/2025 Restricted Stock Units im Rahmen des Amrize Ltd 2025 Omnibus Incentive Plan. Es wurden zwei Zuteilungen gemeldet: 36,952 RSUs, die am 21. März 2026 vesten, und 18,687 RSUs, die am 21. März 2027 vesten. Beide Zuteilungen sind mit einem Preis von $0 verbucht.

Nach diesen gemeldeten Transaktionen zeigt die Einreichung, dass die meldepflichtige Person unmittelbar beteiligungsberechtigt 55,639 Stammaktien besitzt. Die Einträge werden als Erwerb von nicht-derivativen Wertpapieren (Restricted Stock Unit-Zuteilungen) dargestellt, wobei der Vesting-Zeitplan und die Herkunft der Zuteilung in den Erläuterungen ausdrücklich angegeben sind.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Gosa James J

(Last) (First) (Middle)
GRAFENAUWEG 8

(Street)
ZUG V8 6300

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Amrize Ltd [ AMRZ ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
President, Building Envelope
3. Date of Earliest Transaction (Month/Day/Year)
08/11/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Ordinary Shares 08/11/2025 A 36,952(1) A $0 36,952 D
Ordinary Shares 08/11/2025 A 18,687(2) A $0 55,639 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Restricted stock unit award to the reporting person pursuant to the Amrize Ltd 2025 Omnibus Incentive Plan. The award vests on March 21, 2026.
2. Restricted stock unit award to the reporting person pursuant to the Amrize Ltd 2025 Omnibus Incentive Plan. The award vests on March 21, 2027.
Hans Weinburger, Attorney-in-Fact 08/12/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the Amrize (AMRZ) Form 4 report about insider James J. Gosa?

The Form 4 reports that James J. Gosa was awarded restricted stock units totaling 55,639 ordinary shares on 08/11/2025 under the Amrize Ltd 2025 Omnibus Incentive Plan.

How many RSUs were granted and when do they vest for AMRZ insider filings?

Two RSU grants were reported: 36,952 units vesting on March 21, 2026 and 18,687 units vesting on March 21, 2027.

Does the Form 4 show any cash proceeds from the transactions for AMRZ?

No cash proceeds are reported; both awards are recorded with a $0 price in the filing.

What is the reporting person’s beneficial ownership after the reported transactions?

The filing reports the reporting person’s direct beneficial ownership following the transactions as 55,639 ordinary shares.

Were any derivative securities reported in this AMRZ Form 4?

No. Table II for derivative securities contains no entries; only non‑derivative restricted stock unit awards are reported.
Amrize Ltd

NYSE:AMRZ

AMRZ Rankings

AMRZ Latest News

AMRZ Latest SEC Filings

AMRZ Stock Data

28.74B
493.12M
7.13%
36.87%
0.56%
Building Materials
Cement, Hydraulic
Switzerland
ZUG